A Study Evaluating the Safety and Efficacy of the LentiGlobin® BB305 Drug Product in Beta-Thalassemia Major Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01745120
Recruitment Status : Completed
First Posted : December 7, 2012
Last Update Posted : March 30, 2018
Information provided by (Responsible Party):
bluebird bio